AzTrials
AzTrials

Occupational GroupsNCT05100108

A Dog-assisted Therapy to Reduce Burnout Among Professionals Working in a School for Special Education

A study testing Dog-assisted therapy in people with Occupational Groups and Work Related Stress, run by Daniel Collado-Mateo at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This randomized controlled trial aims to evaluate the effects of an 8-week program consisting of dog-assisted therapy on the work engagement, burnout, pain, and quality of life among professionals working in a School for Special Education. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Occupational Groups, Work Related Stress
What is being tested?
Dog-assisted therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSpain
Study dates
26 Oct 2021to 23 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • be aged >18 years
  • be workers in a School for Special Education
  • work in direct contact with children (teachers, physiotherapists, etc.)

Who cannot join

  • People with dog-allergy
  • People with dog phobia
  • People with a history of impulsive animal aggression

Trial locations and contacts

1 site in 1 country.

Daniel Collado-Mateo, PhD contact

+34 914 88 75 18

daniel.collado@urjc.es

Spain1 site, 1 recruiting
  • King Juan Carlos University

    Móstoles, Madrid, 28933

    Daniel Collado-Mateo, PhD, daniel.collado@urjc.es

    Beatriz Rivera Martín, PhD

    Recruiting

Other trials in Spain

About this study

Official title: Effects of a Dog-assisted Therapy on Quality of Life, Work Engagement and Burnout Among Professionals Working in a School for Special Education

This randomized controlled trial aims to evaluate the effects of an 8-week program consisting of dog-assisted therapy on the work engagement, burnout, pain, and quality of life among professionals working in a School for Special Education. A total of 30 participants will be involved in the program, which will be comprised of eight 50-min sessions conducted once a week. The hypothesis of the researchers in this study is that this program will achieve a reduction in burnout levels in workers, as well as an improvement in engagement and quality of life.

Read the detailed description

Animal-assisted interventions have shown numerous benefits in different populations including children with cerebral palsy or autism spectrum disorder, people with chronic pain, older adults, or people in prison. Recently, different initiatives have been carried out focused on improving the work environment, especially among professionals in clinical settings and obtaining benefits in mood, as well as a reduction in the levels of stress and burnout of employees. In addition, it has also been observed that these animals in the workplace can produce an improvement in health, productivity or job satisfaction.

The presence of stress or anxiety among professionals working in Special Education Schools has been previously reported and could increase burnout and reduce the engagement and health-related quality of life of these workers.

Therefore, the current randomized controlled trial aims to evaluate the effects of an 8-week program consisting of dog-assisted therapy on the work engagement, burnout, pain, and quality of life among professionals working in a School for Special Education. A total of 30 participants will be involved in the program, which will be comprised of eight 50-min sessions conducted once a week. The hypothesis of the researchers is that this program will achieve a reduction in burnout levels in workers, as well as an improvement in engagement and quality of life.

Being tested
Dog-assisted therapy
Keywords
dog-assisted, Burnout, Quality of life, Work Engagement, Human-animal interaction, Animal-assisted
Medical subject headings
Occupational Stress, Burnout, Psychological, Human-Animal Interaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dog-assisted therapyBehavioural

    Also called animal-assisted therapy, animal-assisted intervention

    The program will involve 8 sessions, conducted once a week for 8 weeks. Each session will include three parts: 1) a welcome part aimed to get in touch with the dog, 2) a main part, where participants will be taught basic notions about dog training and then try to train the dogs. In this part, the patients will perform different activities and exercises with the dog. 3) A closing part to relaxation and say goodbye to the dogs.

Study groups in NCT05100108
Study groupRoleWhat they receive
Control groupNo interventionThey will be on a waiting list. They will be assessed before and after the 8 week program but will not take part in it.
Experimental groupExperimentalParticipants in this group will take part in the 8 sessions of dog-assisted therapy. They will be assessed before and after the 8 week program.
Receives: Behavioral: Dog-assisted therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Burnout levels assessed using the Burnout Clinical Subtypes Questionnaire

    The Burnout Clinical Subtypes Questionnaire (BCSQ-36) evaluates by means of 36 items the burnout of the participants. Each of the items can be scored on a Likert scale from 1 to 7; 1 being totally disagree and 7 being totally agree. In addition, the questionnaire is divided into 3 subtypes with their respective dimensions: Frantic subtype (Involvement, Ambition and Overload), Unchallenged subtype (Indifference, Boredom and Lack of Development), Worn-out subtype (Abandonment, Lack of Control and Lack of Recognition). The Burnout Clinical Subtypes Questionnaire (BCSQ-12) also assesses burnout and is calculated with the items of the BCSQ-36.

    Measured: At baseline and immediately after the intervention (within 7 days after the last session)

  2. Changes in Burnout levels assessed using the Burnout Maslach Burnout Inventory (MBI)

    The Burnout Maslach Burnout Inventory (MBI) is a tool for the assessment of burnout, as an antithesis of the UWES questionnaire focused on engagement. This questionnaire consists of 22 items that give rise to 3 dimensions: Emotional exhaustion (decrease and loss of energy or emotional resources); Depersonalization or Cynicism (negative attitudes and feelings towards the people for whom the work is intended) and Lack of personal accomplishment or professional efficacy (tendency of professionals to evaluate themselves negatively).

    Measured: At baseline and immediately after the intervention (within 7 days after the last session)

  3. Changes in Burnout levels assessed using one Item for Burnout assessment

    One Item for Burnout assessment where under the statement of "In general, according to your definition of burnout, how would you rate your level of burnout?" participants have 5 response options from "I enjoy my work. I have no symptoms of burnout" to "I feel completely burned out and often wonder if I can keep going. I am at a point where I may need some changes or should seek some kind of help."

    Measured: At baseline and immediately after the intervention (within 7 days after the last session)

Secondary outcomes (5)
  1. Changes in work engagement

    Assessed through the Utrecht Work Engagement Scale (UWES), which is a scale widely used for the evaluation of engagement in the workplace . It is composed of 17 items distributed in three factors: 1) vigor (6 items, e.g., "In my work I feel full of energy"), 2) dedication (6 items, e.g., "My work has meaning") and 3) absorption (5 items, e.g., "When I am working I forget everything that happens around me"). It consists of a seven-item Likert scale (from 0 = "never" to 6 = "always").

    Measured: At baseline and immediately after the intervention (within 7 days after the last session)

  2. Changes in Health-related quality of life

    It will be assessed using the EQ-5D-5L Questionnaire (EuroQoL 5 dimensions 5 levels): it is a questionnaire consisting of 5 dimensions with 5 levels of response, the first dimension refers to mobility, the second to personal care, the third to daily activities, the fourth to pain/discomfort, and the fifth to anxiety and depression.

    Measured: At baseline and immediately after the intervention (within 7 days after the last session)

  3. Changes in Health Status

    It will be assessed using the Visual Analog Scale of the EQ-5D-5L Questionnaire (EuroQoL 5 dimensions 5 levels). It is represented as a thermometer ranging from 0 to 100, where 0 is the worst state of health that can be imagined and 100 is the best state of health imaginable.

    Measured: At baseline and immediately after the intervention (within 7 days after the last session)

  4. Changes in pain

    Assessed through a visual analog pain scale, which is represented as a thermometer ranging from 0 to 100, where 0 is the absence of pain and 100 the highest pain level imaginable

    Measured: At baseline and immediately after the intervention (within 7 days after the last session)

  5. Changes in blood pressure

    Systolic and diastolic blood pressure using the Omron MIT Elite Plus Oscillometer

    Measured: At baseline and immediately after the intervention (within 7 days after the last session)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2021
  2. Study start26 Oct 2021 (estimated)
  3. Primary completion23 Dec 2021 (estimated)
  4. Study completion23 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial with two groups: a) the experimental group and b) a control group (waiting list)
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05100108
Sponsor's protocol ID
AAI_Teachers
Status last verified
Oct 2021
First submitted
16 Oct 2021
Last updated
29 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Dog-assisted therapy in people with Occupational Groups and Work Related Stress, run by Daniel Collado-Mateo at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Daniel Collado-Mateo, PhD (+34 914 88 75 18, daniel.collado@urjc.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Burnout levels assessed using the Burnout Clinical Subtypes Questionnaire (time frame: At baseline and immediately after the intervention (within 7 days after the last session)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in